Abstract
Important recent advances have been made in the management of newborn infants with respiratory distress. Few therapeutic maneuvers have had a greater impact than surfactant and extracorporeal membrane oxygenation (ECMO). Surfactant is a relatively inexpensive drug, administered quite easily through an endotracheal tube, and has had its greatest impact on the premature infant population in whom ECMO is usually contraindicated. Conversely, ECMO is a highly advanced, expensive, time and staff intensive, technically demanding procedure used mostly in full-term babies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Long WA, Guangbin Z, Henry GW (1996) Pharmacologic adjuncts IL exogenous surfactants. In: Goldsmith JP, Karotkin EH (eds) Assisted ventilation of the neonate, 3rd edn. WB Saunders, Philadelphia. pp 305–325
Avery ME, Mead J (1959) Surface active properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 17: 517–523
Chu J, Clements JA, Cotton EK. et al. (1967) Neonatal pul-monary ischemia. Part 1: clinical and physiological studies. Pediatrics 40: 709–782
Robillard E, Alaire Y, Dagenais-Perusse P, et al. (1964) Microaerosol administration of synthectic beta-gamma-dipalmitoyl-L-alpha-lecithin in the respiratory distress syndrome: a preliminary report. Can Med Assoc J 90: 55–57
Hawgood S, Clements JA (1990) Surfactant and its apoproteins. J Clin Invest 86: 1
Soll RF (1997) Surfactant therapy in the USA: trials and current routines. Biol Neonate 71 (Suppl 1): 1–7
Fujiwara T, Chida S, Watabe Y, et al. (1980) Artificial surfactant therapy in hyaline membrane disease. Lancet 1: 55–59
Hennes HM, Lee MB, Rimm AA, Shapiro DL (1991) Surfactant replacement therapy in respiratory distress syndrome. AJDC 145: 102–104
Dunn MS, Shennan AT, Possmayer F (1990) Single-versus multiple-dose surfactant replacement therapy in neonates of 30–36 weeks’ gestation with respiratory distress syndrome. Pediatrics 86: 564–571
Phibbs RH, Ballard RA, Clements JA, Heilbron DC, Phibbs CS. Schlueter MA, et al. (1991) Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of Hyaline membrane disease. Pediatrics 88: 1–9
Jobe AH (1993) Pulmonary surfactant therapy. N Engl J Med 328: 861–868
McColley SA (1998) Bronchopulmonary dysplasia. Impact of surfactant replacement therapy. Pediatr Clin North Am 45: 573–585
Kattwinkel J (1998) Surfactant: evolving issues. Clin Perinatol 25: 17–32
Soll RF (1996) Appropriate surfactant usage in 1996. Eur J Pediatr 155 (Suppl 2): 8–13
Morley CJ (1997) Systematic review of prophylactic vs rescue surfactant. Arch Dis Child 77: F70–F74
Schimmel MS (1995) Respiratory distress syndrome: therapeutic aspects. Pediatr Radiol 25: 641–642
Dinger J, Schwarze R, Rupprecht E (1997) Radiological changes after therapeutic use of surfactant in infants with respiratory distress syndrome. Pediatr Radiol 27: 26–31
Skinner JR (1997) The effects of surfactant on haemodynamics in hyaline membrane disease. Arch Dis Child Fetal Neonatal Ed 76: F67–F69
Lotze A, Mitchell BR, Bulas DI, Zola EM, Shalwitz RA, Gunkel JH, et al. (1998) Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. J Pediatr 132: 40–47
Cleveland RH (1995) A radiologic update on medical diseases of the newborn chest. Pediatr Radiol 25: 631–637
Dimitriou G, Greenough A, Griffin FJ, Karani J (1995) The appearance of “early” chest radiographs and the response to surfactant replacement therapy. Br J Radiol 68: 1177–1180
Swischuk LE, Shetty BP, John SD (1996) The lungs in immature infants: how important is surfactant therapy in preventing chronic lung problems? Pediatr Radiol 26: 508–511
Soll RF (1998) Surfactant treatment of the very preterm infant. Biol Neonate 74 (Suppl 1): 35–42
Clyman RI, Jobe A, Heymann M, Ikegami M, Roman C, Payne B, et al. (1982) Increased shunt through the patent ductus arteriosus after surfactant replacement therapy. J Pediatr 100: 101–107
Wood BP (1993) The newborn chest. Radiol Clin North Am 31: 667–676
Hamvas A, Nogee LM, Mallory GB Jr., Spray TL, Huddleston CB, August A, et al. (1997) Lung transplantation for treatment of infants with surfactant protein B deficiency. J Pediatr 130: 231–239
Goetzman BW. Milstein JM (1996) Pharmacologic adjuncts I. In: Goldsmith JP. Karotkin EH (eds) Assisted ventilation of the neonate. WB Saunders, Philadelphia, pp 296–300
Northway WH (1992) Bronchopulmonary dysplasia: twenty-five years later. Pediatrics 89: 969–973
Kanto WP Jr, Bunyapen C (1998) Extracorporeal membrane oxygenation. Controversies in selection of patients and management. Clin Perinatol 25: 123–135
Langer JC (1998) Congenital diaphragmatic hernia. Chest Surg Clin N Am 8: 295–314
Stillerman LR, Gunn SB, Hart JC, Engle WA (1997) Effects of exogenous surfactant on neonates supported by extracorporeal membrane oxygenation. J Perinatol 17: 262–265
Torosian MB, Statter MB, Arensman RM (1996) Extracor poreal membrane oxygenation. In: Goldsmith JP, Karotkin EH, (eds) Assisted ventilation of the neonate, 3rd edn. WB Saunders, Philadelphia, pp 241–256
Bartlett RH, Gazzaniga AB, Jefferies MR, et al. (1976) Extracorporeal membrane oxygenation ( ECMO) cardiopulmonary support in infancy. Trans Am Soc Artif Intern Organs 22: 80–93
Fox WW, Dura S (1983) Persistent pulmonary hypertension in the neonate: diagnosis and management. J Pediatr 103: 505–514
Bartlett RH, Toomasian J, Roloff D, et al. (1986) Extracorporeal membrane oxygenation in neonatal respiratory failure: 100 cases. Ann Surg 204: 236–245
Short BL, Miller MK, Anderson KD (1987) Extracorporeal membrane oxygenation in the management of respiratory failure in the newborn. Clin Perinatol 14: 737–748
Redmond CR, Graves ED, Falterman KW, et al. (1987) Extracorporeal membrane oxygenation for respiratory and cardiac failure in infants and children. J Thorac Cardiovasc Surg 93: 199–204
Swischuk LE (1997) Imaging of the newborn, infant, and young child, 4th edn. Williams & Wilkins, Baltimore, pp 105–107
Knight GR, Dudell GG, Evans ML, Grimm PS (1996) A comparison of venovenous and venoarterial extracorporeal membrane oxygenation in the treatment of neonatal respiratory failure. Crit Care Med 24: 1678–1683
Cornish JD, Heiss KF, Clark RH, et al. (1993) Efficacy of venovenous extracorporeal membrane oxygenation for neonates with respiratory and circulatory compromise. J Pediatr 122: 105–109
DeAngelis GA, Mitchell DG, Merton DA, Wolfson PJ, Desai HJ, Desai SA, et al. (1992) Right common carotid artery reconstruction in neonates after extracorporeal membrane oxygenation: color Doppler imaging. Radiology 182: 521–525
Gross GW, Cullen J, Kornhauser MS, Wolfson PJ (1992) Thoracic complications of extracorporeal membrane oxygenation: findings on chest radiographs and sonograms. AJR 158: 353–358
Taylor GA, Short BL, Kriesmer P (1986) Extracorporeal membrane oxygenation: radiographic appearance of the neonatal chest. AJR 146: 1257–1260
Kelly RE, Phillips JD, Foglia RP, et al. (1991) Pulmonary edema and fluid mobilization as determinants of the duration of ECMO support. J Pediatr Surg 26: 1016–1022
Zwischenberger JB, Nguyen TT, Upp JR Jr, et al. (1994) Complications of neonatal extracorporeal membrane oxygenation. Collective experience from the Extracorporeal Life Support Organization. J Thorac Cardiovasc Surg 107: 838–848
Weber TR, Kountzman B (1996) The effects of venous occlusion on cerebral blood flow characteristics during ECMO. J Pediatr Surg 31: 1124–1127
Kornhauser MS, Cullen JA, Baumgart S. et al. (1994) Risk factors for bronchopulmonary dysplasia after extracorporeal membrane oxygenation. Arch Pediatr Adolesc Med 148: 820–825
Graziani LJ. Gringlas M, Baumgart S (1997) Cerebrovascular complications and neurodevelopmental sequelae of neonatal ECMO. Clin Perinatol 24: 655–675
Bulas DI, Taylor GA, O’Donnell RM, Short BL, Fitz CR, Vezina G (1996) Intracranial abnormalities in infants treated with extracorporeal membrane oxygenation: update on sonographic and CT findings. AJNR 17: 287–294
Hofkosh D, Thompson AE, Nozza RJ, et al. (1991) Ten years of extracorporeal membrane oxygenation: neurodevelopmental outcome. Pediatrics 87: 549–555
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Italia, Milano
About this paper
Cite this paper
Newman, B. (1999). “Face Lifting” of the Newborn Chest-Surfactant and Extracorporeal Membrane Oxygenation. In: Bar-Ziv, J., Horev, G., Kalifa, G. (eds) Highlights of Pediatric Radiology. Syllabus. Springer, Milano. https://doi.org/10.1007/978-88-470-2253-9_1
Download citation
DOI: https://doi.org/10.1007/978-88-470-2253-9_1
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0061-2
Online ISBN: 978-88-470-2253-9
eBook Packages: Springer Book Archive